BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36108931)

  • 1. Molecular characterization of adenocarcinomas arising in the urinary bladder following augmentation cystoplasty: a multi-institutional study.
    Stohr BA; Chan E; Anderson JA; Matoso A; Murati Amador BI; Cheng L; Osunkoya AO
    Hum Pathol; 2022 Nov; 129():98-102. PubMed ID: 36108931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study.
    Anderson JA; Matoso A; Murati Amador BI; Cheng L; Stohr BA; Chan E; Osunkoya AO
    Pathology; 2021 Feb; 53(2):214-219. PubMed ID: 32951908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Villous Adenoma Arising in the Native Bladder Mucosa and the Upper Urinary Tract With Coexisting Neuroendocrine Carcinoma Following Augmentation Cystoplasty.
    Nayak A; Depasquale B; Vergara N; Guzzo TA; Lal P
    Int J Surg Pathol; 2019 Jun; 27(4):450-456. PubMed ID: 30701999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma.
    Eich ML; Rodriguez Pena MDC; Springer SU; Taheri D; Tregnago AC; Salles DC; Bezerra SM; Cunha IW; Fujita K; Ertoy D; Bivalacqua TJ; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Netto GJ
    Mod Pathol; 2019 Oct; 32(10):1544-1550. PubMed ID: 31028363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urothelial carcinoma following augmentation cystoplasty: an aggressive variant with distinct clinicopathological characteristics and molecular genetic alterations.
    Sung MT; Zhang S; Lopez-Beltran A; Montironi R; Wang M; Davidson DD; Koch MO; Cain MP; Rink RC; Cheng L
    Histopathology; 2009 Aug; 55(2):161-73. PubMed ID: 19694823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancy after Augmentation Enterocystoplasty: A Nationwide Study of Natural History, Prognosis and Oncogene Panel Analysis.
    Garnier S; Vendrell J; Boillot B; Karsenty G; Faure A; Blanc T; Soustelle L; Phe V; Even A; Chartier-Kastler E; Ravasse P; Poinas G; Leizour B; Costa P; Galmiche L; Iborra F; Bouali O; Game X; Solassol J; Kalfa N
    J Urol; 2020 Jul; 204(1):136-143. PubMed ID: 31957550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder.
    Soergel TM; Cain MP; Misseri R; Gardner TA; Koch MO; Rink RC
    J Urol; 2004 Oct; 172(4 Pt 2):1649-51; discussion 1651-2. PubMed ID: 15371782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma.
    Roy S; Pradhan D; Ernst WL; Mercurio S; Najjar Y; Parikh R; Parwani AV; Pai RK; Dhir R; Nikiforova MN
    Mod Pathol; 2017 Aug; 30(8):1133-1143. PubMed ID: 28548125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of malignancy after augmentation cystoplasty: A systematic review.
    Biardeau X; Chartier-Kastler E; Rouprêt M; Phé V
    Neurourol Urodyn; 2016 Aug; 35(6):675-82. PubMed ID: 25867054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of adenocarcinoma by urinary microsatellite analysis after augmentation cystoplasty.
    Docimo SG; Chow NH; Steiner G; Silver RI; Rodriguez R; Kinsman S; Sidransky D; Schoenberg M
    Urology; 1999 Sep; 54(3):561. PubMed ID: 10754137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladder.
    Alexander RE; Montironi R; Lopez-Beltran A; Williamson SR; Wang M; Post KM; Sen JD; Arnold AK; Zhang S; Wang X; Koch MO; Hahn NM; Masterson TA; MacLennan GT; Davidson DD; Compérat E; Cheng L
    Mod Pathol; 2014 Jan; 27(1):107-12. PubMed ID: 23887300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of tumors in experimental gastroenterocystoplasty.
    Buson H; Diaz DC; Manivel JC; Jessurun J; Dayanc M; Gonzalez R
    J Urol; 1993 Aug; 150(2 Pt 2):730-3. PubMed ID: 8326635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
    Oliva E; Amin MB; Jimenez R; Young RH
    Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinoma arising from tubulovillous adenoma in a native bladder following gastrocystoplasty.
    Lin TP; Chen M; Hsu JM; Sheu JC
    Pediatr Surg Int; 2014 Jan; 30(1):123-6. PubMed ID: 24030813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype.
    Almassi N; Whiting K; Toubaji A; Lenis AT; Jordan EJ; Won H; Regazzi AM; Chen YB; Gopalan A; Sirintrapun SJ; Fine SW; Tickoo SK; Ostrovnaya I; Pietzak EJ; Cha EK; Goh AC; Donahue TF; Herr HW; Donat SM; Dalbagni G; Bochner BH; Teo MY; Funt SA; Rosenberg JE; Reuter VE; Bajorin DF; Solit DB; Al-Ahmadie H; Iyer G
    JCO Precis Oncol; 2022 Jun; 6():e2100392. PubMed ID: 35731998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder.
    Lee DH; Yoon H; Park S; Kim JS; Ahn YH; Kwon K; Lee D; Kim KH
    Sci Rep; 2018 Oct; 8(1):14707. PubMed ID: 30279572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor in bladder reservoir after gastrocystoplasty.
    Castellan M; Gosalbez R; Perez-Brayfield M; Healey P; McDonald R; Labbie A; Lendvay T
    J Urol; 2007 Oct; 178(4 Pt 2):1771-4; discussion 1774. PubMed ID: 17707009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Genetic Features of Primary Nonurachal Enteric-type Adenocarcinoma, Urachal Adenocarcinoma, Mucinous Adenocarcinoma, and Intestinal Metaplasia/Adenoma: Review of the Literature and Next-generation Sequencing Study.
    Pires-Luis AS; Martinek P; Alaghehbandan R; Trpkov K; Comperat EM; Perez Montiel DM; Bulimbasic S; Lobo J; Henrique R; Vanecek T; Pivovarcikova K; Michalova K; Pitra T; Hora M; Marques A; Lopes JM; Rogala J; Mareckova J; Michal M; Hes O
    Adv Anat Pathol; 2020 Sep; 27(5):303-310. PubMed ID: 32520749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
    Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.